Perrin Steven
Transaction: 07/31/2026
SELL
Change
-72,138
Price
$3.38
Filing
08/04/2026
Type
SELL
Eledon Pharmaceuticals, Inc.
ELDN • Biotechnology
$3.02
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$343.17M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 7.4Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:18 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.02
Change0.00%
Shares Out113.63M
Market Cap$343.17M
Enterprise Value$254.88M
52W Range1.35 - 4.60
Beta0.96
P/E-3.48
P/B10.39
P/FCF-4.65
EV/EBITDA-3.02
EV/FCF-3.45
Price$3.02
Change0.00%
Shares Out113.63M
Market Cap$343.17M
Enterprise Value$254.88M
52W Range1.35 - 4.60
Beta0.96
P/E-3.48
P/B10.39
P/FCF-4.65
EV/EBITDA-3.02
EV/FCF-3.45
Earnings Yield-28.72%
FCF Yield-21.52%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio7.40
Quick Ratio7.40
Target$5.00
Target Upside65.56%
Target Median$5.00
Target Range5.00 - 5.00
Volume622.98K
Avg Volume1.41M
EPS Surprise0.06
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
91/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 7.4Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
100/100
Bullish
Bullish
4
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$5.00
Mean
$5.00
Median
$5.00
High
$5.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Gros David-Alexandre C
Transaction: 07/31/2026
SELL
Change
-194,791
Price
$3.38
Filing
08/04/2026
Type
SELL
Robinson James A. Jr.
Transaction: 01/10/2026
SELL
Change
-3,430
Price
Not reported
Filing
01/16/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Perrin Steven | SELL | -72,138 | $3.38 | 07/31/2026 | 08/04/2026 |
| Gros David-Alexandre C | SELL | -194,791 | $3.38 | 07/31/2026 | 08/04/2026 |
| Robinson James A. Jr. | SELL | -3,430 | Not reported | 01/10/2026 | 01/16/2026 |
| Robinson James A. Jr. | BUY | +3,430 | Not reported | 01/10/2026 | 01/16/2026 |
| Lee June | SELL | -3,430 | Not reported | 01/10/2026 | 01/16/2026 |
| Lee June | BUY | +3,430 | Not reported | 01/10/2026 | 01/16/2026 |
| Katkin Keith | SELL | -8,575 | Not reported | 01/10/2026 | 01/16/2026 |
| Katkin Keith | BUY | +8,575 | Not reported | 01/10/2026 | 01/16/2026 |
| Kirk Allan | SELL | -3,430 | Not reported | 01/10/2026 | 01/16/2026 |
| Kirk Allan | BUY | +3,430 | Not reported | 01/10/2026 | 01/16/2026 |
| Hillson Jan | SELL | -3,430 | Not reported | 01/10/2026 | 01/16/2026 |
| Hillson Jan | BUY | +3,430 | Not reported | 01/10/2026 | 01/16/2026 |
| McBride John S. | SELL | -3,430 | Not reported | 01/10/2026 | 01/16/2026 |
| McBride John S. | BUY | +3,430 | Not reported | 01/10/2026 | 01/16/2026 |
| Robinson James A. Jr. | BUY | +30,870 | $4.04 | 01/10/2035 | 01/13/2025 |
| Kirk Allan | BUY | +3,430 | Not reported | 01/10/2025 | 01/13/2025 |
| Kirk Allan | BUY | +30,870 | $4.04 | 01/10/2025 | 01/13/2025 |
| Robinson James A. Jr. | BUY | +3,430 | Not reported | 01/10/2025 | 01/13/2025 |
| Lee June | BUY | +3,430 | Not reported | 01/10/2025 | 01/13/2025 |
| Lee June | BUY | +30,870 | $4.04 | 01/10/2025 | 01/13/2025 |